449 related articles for article (PubMed ID: 29121154)
21. Lymphopaenia as a predictor of sarcoidosis in patients with a first episode of uveitis.
Groen-Hakan F; Eurelings L; Rothova A; van Laar J
Br J Ophthalmol; 2019 Sep; 103(9):1296-1300. PubMed ID: 30442816
[TBL] [Abstract][Full Text] [Related]
22. Role of Neuron-Specific Enolase in the Diagnosis and Disease Monitoring of Sarcoidosis.
Sunaga N; Koga Y; Hachisu Y; Yamaguchi K; Aikawa M; Kasahara N; Miura Y; Tsurumaki H; Yatomi M; Sakurai R; Maeno T; Hisada T
Can Respir J; 2022; 2022():3726395. PubMed ID: 35663496
[TBL] [Abstract][Full Text] [Related]
23. Conventional markers in determination of activity of sarcoidosis.
Gungor S; Ozseker F; Yalcinsoy M; Akkaya E; Can G; Eroglu H; Genc NS
Int Immunopharmacol; 2015 Mar; 25(1):174-9. PubMed ID: 25623898
[TBL] [Abstract][Full Text] [Related]
24. Soluble interleukin-2 receptor in blood from patients with sarcoidosis and idiopathic pulmonary fibrosis.
Tsutsumi T; Nagai S; Imai K; Setoyama Y; Uchiyama T; Izumi T
Sarcoidosis; 1994 Sep; 11(2):102-9. PubMed ID: 7809492
[TBL] [Abstract][Full Text] [Related]
25. [Serum soluble IL-2 receptor level in patients with sarcoidosis].
Ina Y; Takada K; Noda M; Satou T; Hashiba H; Miyachi A; Ito S; Iijima N; Yamamoto M
Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Mar; 29(3):316-21. PubMed ID: 2067152
[TBL] [Abstract][Full Text] [Related]
26. Sarcoidosis: TNF-alpha release from alveolar macrophages and serum level of sIL-2R are prognostic markers.
Ziegenhagen MW; Benner UK; Zissel G; Zabel P; Schlaak M; Müller-Quernheim J
Am J Respir Crit Care Med; 1997 Nov; 156(5):1586-92. PubMed ID: 9372680
[TBL] [Abstract][Full Text] [Related]
27. Serum concentration of soluble interleukin-2 receptor as a sensitive parameter of disease activity in sarcoidosis.
Keicho N; Kitamura K; Takaku F; Yotsumoto H
Chest; 1990 Nov; 98(5):1125-9. PubMed ID: 2171882
[TBL] [Abstract][Full Text] [Related]
28. [Serum soluble interleukin-2 receptor levels in uveitis].
Xie C; Huang X; Zhou H; Yang P
Yan Ke Xue Bao; 1998 Jun; 14(2):64-5. PubMed ID: 12580032
[TBL] [Abstract][Full Text] [Related]
29. A Multiple Biomarker Approach in Patients with Cardiac Sarcoidosis.
Kiko T; Yoshihisa A; Kanno Y; Yokokawa T; Abe S; Miyata-Tatsumi M; Misaka T; Oikawa M; Kobayashi A; Ishida T; Takeishi Y
Int Heart J; 2018 Sep; 59(5):996-1001. PubMed ID: 30101857
[TBL] [Abstract][Full Text] [Related]
30. Analysis of soluble interleukin-2 receptor as CSF biomarker for neurosarcoidosis.
Otto C; Wengert O; Unterwalder N; Meisel C; Ruprecht K
Neurol Neuroimmunol Neuroinflamm; 2020 Jul; 7(4):. PubMed ID: 32393650
[TBL] [Abstract][Full Text] [Related]
31. Chest Radiographic Screening for Sarcoidosis in the Diagnosis of Patients with Active Uveitis.
Groen F; van Laar JAM; Rothova A
Ann Am Thorac Soc; 2017 Jun; 14(6):912-918. PubMed ID: 28345954
[TBL] [Abstract][Full Text] [Related]
32. Serum lysozyme levels and clinical features of sarcoidosis.
Tomita H; Sato S; Matsuda R; Sugiura Y; Kawaguchi H; Niimi T; Yoshida S; Morishita M
Lung; 1999; 177(3):161-7. PubMed ID: 10192763
[TBL] [Abstract][Full Text] [Related]
33. Usefulness of quantifying serum KL-6 levels in the follow-up of uveitic patients with sarcoidosis.
Kitaichi N; Ariga T; Kase S; Yoshida K; Namba K; Ohno S
Graefes Arch Clin Exp Ophthalmol; 2006 Apr; 244(4):433-7. PubMed ID: 16133026
[TBL] [Abstract][Full Text] [Related]
34. Inflammatory activity assessment by F18 FDG-PET/CT in persistent symptomatic sarcoidosis.
Mostard RL; Vöö S; van Kroonenburgh MJ; Verschakelen JA; Wijnen PA; Nelemans PJ; Erckens RJ; Drent M
Respir Med; 2011 Dec; 105(12):1917-24. PubMed ID: 21899998
[TBL] [Abstract][Full Text] [Related]
35. The clinical value of serum soluble interleukin-2 receptor in pulmonary sarcoidosis.
Ogata-Suetsugu S; Hamada N; Takayama K; Tsubouchi K; Arimura-Omori M; Nakanishi Y
Sarcoidosis Vasc Diffuse Lung Dis; 2017; 34(1):41-47. PubMed ID: 32476821
[No Abstract] [Full Text] [Related]
36. Soluble interleukin-2 receptor levels in hepatocellular cancer: a more sensitive marker than alfa fetoprotein.
Izzo F; Cremona F; Delrio P; Leonardi E; Castello G; Pignata S; Daniele B; Curley SA
Ann Surg Oncol; 1999 Mar; 6(2):178-85. PubMed ID: 10082044
[TBL] [Abstract][Full Text] [Related]
37. Ocular sarcoidosis: when should labial salivary gland biopsy be performed?
Bernard C; Kodjikian L; Bancel B; Isaac S; Broussolle C; Seve P
Graefes Arch Clin Exp Ophthalmol; 2013 Mar; 251(3):855-60. PubMed ID: 23100162
[TBL] [Abstract][Full Text] [Related]
38. [Diagnosis in sarcoidosis. Sensitivity and specificity of 67-gallium scintigraphy, serum angiotensin converting enzyme levels, thoracic radiography and blood lymphocyte subpopulations].
Klech H; Köhn H; Pohl W; Kummer F; Mostbeck A
Wien Med Wochenschr; 1983 Sep; 133(17):425-32. PubMed ID: 6314681
[TBL] [Abstract][Full Text] [Related]
39. Angiotensin-converting enzyme in sarcoid uveitis.
Weinreb RN; O'Donnell JJ; Sandman R; Char DH; Kimura SJ
Invest Ophthalmol Vis Sci; 1979 Dec; 18(12):1285-7. PubMed ID: 229083
[TBL] [Abstract][Full Text] [Related]
40. Clinical significance of serum and vitreous soluble interleukin-2 receptor in patients with intraocular lymphoma.
Suzuki K; Namba K; Kase S; Ogino Y; Hase K; Iwata D; Mizuuchi K; Hiraoka M; Kitaichi N; Ishida S
BMC Ophthalmol; 2022 Nov; 22(1):428. PubMed ID: 36357882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
